CompanyHealthAi
Gordian Biotechnology
Gordian Biotechnology is a South San Francisco in vivo drug discovery company building a high-throughput screening platform that tests hundreds of gene therapies simultaneously inside animals that naturally develop age-related diseases. By pairing 'patient avatar' models with single-cell transcriptomics and machine learning (a stack the company calls Mosaic Screening + Pythia), Gordian aims to predict human clinical outcomes earlier and cure complex diseases of aging.
2018Founded
South San FranciscoHQ
$60,000,000Venture (round not specified)
biotechdrug-discoveryaginglongevitygene-therapyin-vivo-screening